• Tue, February 20, 2024

Robert Burns Maintained (YMAB) at Strong Buy with Increased Target to $21 on, Feb 20th, 2024

Robert Burns of HC Wainwright & Co., Maintained "Y-mAbs Therapeutics, Inc." (YMAB) at Strong Buy with Increased Target from $11 to $21 on, Feb 20th, 2024.

Robert, nor any peers, have made any analyst calls on YMAB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍